4-CHLORO-7-ETHYL-7H-IMIDAZO[4,5-C]PYRIDAZINE, 95%, 1g

3-[3,5-Bis(trifluoromethyl)phenyl]prop-2-yn-1-ol, 95.0%, 5g

Flacon rond 250 ml HD/LD PE blanc RD 32 cylindrique

5-(3-chlorophenyl)-1H-1,2,3,4-tetrazole, 95%, 25g

2-(5-Chloropyridin-2-yl)acetonitrile, 95.0%, 1g

3-phenyl-5-pyrrolidin-2-yl-1,2,4-oxadiazole, 95.0%, 250mg

(R)-3-((tert-Butoxycarbonyl)amino)-3-(2-methoxyphenyl)propanoic acid, 95.0%, 1g

6-Benzyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-2,4(1H,3H)-dione, 95.0%, 5g

Oxo-piperazin-1-yl-acetic acid, 98.0%, 5g

(R)-1-(2-Fluoro-4-methylphenyl)ethanamine hydrochloride, 250mg

N-([1,1'-Biphenyl]-4-yl)-9-phenyl-9H-carbazol-3-amine, 98%, 25g

tert-Butyl 4-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene)azepane-1-carboxylate, 98%, 1g

tert-Butyl (5-aminopyridin-2-yl)carbamate, 95.0%, 10g